Skip to main content
Premium Trial:

Request an Annual Quote

Veracyte: Rob Brainin, Bill Zondler

Veracyte has appointed Rob Brainin as executive vice president and chief business officer, and Bill Zondler as senior vice president and chief information officer.

Brainin most recently served as CEO of Genuity Science (formerly known as WuXi NextCode). Prior to that, he was vice president and general manager of life sciences and applied genomics at Illumina. He also previously served as vice president and general manager of enterprise genomics solutions at Thermo Fisher Scientific, after having held a number of positions at Life Technologies and its predecessor, Invitrogen. Earlier in his career, Brainin was a management consultant at McKinsey & Co. and has served as an adjunct professor at the University of San Diego School of Law. He is a member of the board of directors of Champions Oncology and the Children's Tumor Foundation. He holds a bachelor's degree in in economics from Emory University and a JD degree from Harvard Law School.

Zondler joins Veracyte from Biotheranostics, part of Hologic, where he served as CIO. Prior to that, he was the full-time consulting CIO at Axovant Sciences, a New York-based pharmaceutical firm. He has also previously served as CIO at Millennium Health; vice president of information services and CIO at Prometheus Laboratories; and vice president of information technologies and facilities at Sanford Burnham Prebys Medical Discovery Institute in San Diego.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.